why choose us

First received: November 16, 2022

Clinical Trial: Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Study Status: Completed

Recruit Status: Completed

Condition: Intraocular Inflammation
Retinal Vascular Occlusion

Study Type: Observational


Official Title: Retrospective Analysis of Imaging and Clinical Features From Patients Treated With Brolucizumab in Post-marketing Setting With Reports of Intraocular Inflammation and/or Retinal Vascular Occlusion

Brief Summary: This non-interventional descriptive study was undertaken to better understand the most common imaging features associated with inflammation arising in the post-marketing setting when brolucizumab was prescribed in routine clinical practice.

Read more